Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-04-13

Clinical Trial Update: Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT [NA]

View source ↗

Summary

This completed trial evaluated whether supplementary oxygen improves dyspnea and exercise tolerance in COPD patients receiving long-term oxygen therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxygen (supplementary oxygen therapy) (oxygen)

Snippet

Sponsor: LHL Helse | Conditions: COPD | NA | Status: COMPLETED